As of 28 Aug 2026, Piramal Pharma Ltd share price is ₹214.90. The stock opened at ₹214.90 and had closed at ₹211.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹132.50 and a high of ₹220.40. In terms of performance, Piramal Pharma Ltd share price has increased by 33.52% over the past six months and has increased by 17.05% over the last year.
PPLPHARMA Charts
Piramal Pharma Ltd Overview
About PPLPHARMA
Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (“APIs”), Finished dosage forms (“FDFs”), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG“) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and Piramal Consumer Healthcare (“PCH“) business, selling well-known OTC brands.
Piramal Pharma Ltd Historical Performance
Piramal Pharma Ltd Fundamental Analysis
Piramal Pharma Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 1,239.58 | 1,672.75 | 1,291.96 | 1,329.23 | 1,150.80 |
| EBITDA | 231.57 | 421.47 | 236.46 | 329.04 | 225.25 |
| Net Profit | 113.48 | 261.63 | 128.91 | 196.33 | 113.14 |
| EPS | 0.85 | 1.97 | 0.97 | 1.48 | 0.85 |
Piramal Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 60.63 |
| MACD | 6.67 |
| 20-Day SMA | 208.02 |
Piramal Pharma Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Piramal Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Piramal Pharma Ltd today is ₹214.90 on NSE and ₹214.90 on BSE.
- The 52-week high of Piramal Pharma Ltd is ₹220.40, while the 52-week low is ₹132.50.
- The current market capitalisation of Piramal Pharma Ltd is approximately ₹28,611 crore.
- The P/E (Price-to-Earnings) ratio of Piramal Pharma Ltd is -124.47. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Piramal Pharma Ltd is 2.52. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Piramal Pharma Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Piramal Pharma Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Piramal Pharma Ltd has delivered a return of approximately 113.09%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Piramal Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 34.80% promoters, -0.67% FIIs, 14.57% DIIs, and 14.54% public shareholders.
